Comments
Suven Life Sciences Ltd has obtained two products patents, one each from Europe and Macau, for its New Chemical Entities (NCEs) for the treatment of neurodegenerative diseases.
The granted claims of the patents include the class of selective alpha 4-beta 2 compounds discovered by Suven and are being developed as therapeutic agents for major depressive disorder, the Hyderabad-based company said in a release issued here on Tuesday.
Suven Life Sciences’ scrip gained 3.84 per cent after opening of trade on the Bombay Stock Exchange on Tuesday and is trading at Rs 272.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.